Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$0.16 - $0.64 $2 - $9
15 Added 19.74%
91 $0
Q1 2023

May 12, 2023

BUY
$0.44 - $0.81 $0 - $0
1 Added 1.33%
76 $0
Q4 2022

Feb 13, 2023

BUY
$0.39 - $28.0 $1 - $84
3 Added 4.17%
75 $0
Q2 2022

Aug 12, 2022

SELL
$0.64 - $2.66 $54 - $226
-85 Reduced 54.14%
72 $0
Q1 2022

May 16, 2022

BUY
$2.19 - $3.82 $203 - $355
93 Added 145.31%
157 $0
Q4 2021

Feb 14, 2022

BUY
$2.93 - $4.19 $20 - $29
7 Added 12.28%
64 $0
Q3 2021

Nov 15, 2021

BUY
$3.17 - $4.61 $9 - $13
3 Added 5.56%
57 $0
Q2 2021

Aug 16, 2021

BUY
$3.71 - $5.18 $14 - $20
4 Added 8.0%
54 $0
Q4 2020

Feb 09, 2021

BUY
$3.0 - $9.47 $150 - $473
50 New
50 $0

Others Institutions Holding INVO

# of Institutions
1
Shares Held
14.1K
Call Options Held
0
Put Options Held
0

About INVO Bioscience, Inc.


  • Ticker INVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,169,700
  • Market Cap $9.74M
  • Description
  • INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
More about INVO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.